Inovio Pharmaceuticals, Inc.
Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy

Last updated:

Abstract:

Disclosed herein is a vaccine comprising an antigen and checkpoint inhibitor. Also disclosed herein is a method for enhancing an immune response in a subject. The method may comprise administering the vaccine to the subject in need thereof.

Status:
Grant
Type:

Utility

Filling date:

28 Jan 2016

Issue date:

14 Sep 2021